YOUR BUSINESS AUTHORITY
Springfield, MO
AbbVie signed on to buy rival drugmaker Allergan for $63 billion.
The bid values Allergan's shares at a 45% premium.
The acquisition would combine AbbVie, the maker of arthritis drug Humira, and Allergan, which is known for its wrinkle treatment Botox, among other products.
Read more from Bloomberg.
Survey data reveals how businesses are navigating credit access, financing strategies and growth plans.
A week into city manager job, Cameron points to goals for Springfield
Bambinos reopens in Phelps Grove
St. Louis University lists campus building, 18 acres for sale
Report: US attorneys to be named for Missouri federal court districts
STL airport has busiest day on record